Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats
Interest in the potential therapeutic efficacy of psilocybin and other psychedelic compounds has escalated significantly in recent years. To date, little is known regarding the biological activity of the psilocybin pathway intermediate, norbaeocystin, due to limitations around sourcing the phosphory...
Main Authors: | Alexandra M. Adams, Nicholas A. Anas, Abhishek K. Sen, Jordan D. Hinegardner-Hendricks, Philip J. O’Dell, William J. Gibbons, Jr., Jessica E. Flower, Matthew S. McMurray, J. Andrew Jones |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-06-01
|
Series: | Metabolic Engineering Communications |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2214030122000050 |
Similar Items
-
Effect of oral tryptamines on the gut microbiome of rats—a preliminary study
by: Mengyang Xu, et al.
Published: (2024-06-01) -
Research on Acute Toxicity and the Behavioral Effects of Methanolic Extract from Psilocybin Mushrooms and Psilocin in Mice
by: Olga Zhuk, et al.
Published: (2015-03-01) -
Psilocybin-assisted therapy and HIV-related shame
by: Nicky J. Mehtani, et al.
Published: (2024-08-01) -
Neuroprotective effects of psilocybin in a rat model of stroke
by: Seong-Jin Yu, et al.
Published: (2024-10-01) -
Psychedelics and psychiatric disorders: A emerging role
by: C. Peixoto, et al.
Published: (2021-04-01)